<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="58524">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01661634</url>
  </required_header>
  <id_info>
    <org_study_id>ULA01</org_study_id>
    <secondary_id>2010-024249-59</secondary_id>
    <nct_id>NCT01661634</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Ularitide for the Treatment of Acute Decompensated Heart Failure</brief_title>
  <acronym>TRUE-AHF</acronym>
  <official_title>Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Ularitide (Urodilatin) Intravenous Infusion in Patients Suffering From Acute Decompensated Heart Failure [TRUE-AHF]</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cardiorentis</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Quintiles</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Cardiorentis</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <authority>Czech Republic: State Institute for Drug Control</authority>
    <authority>Denmark: Danish Health and Medicines Authority</authority>
    <authority>Estonia: The State Agency of Medicine</authority>
    <authority>Finland: Finnish Medicines Agency</authority>
    <authority>France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)</authority>
    <authority>Germany: Federal Institute for Drugs and Medical Devices</authority>
    <authority>Hungary: National Institute of Pharmacy</authority>
    <authority>Italy: The Italian Medicines Agency</authority>
    <authority>Latvia: State Agency of Medicines</authority>
    <authority>Lithuania: State Medicine Control Agency - Ministry of Health</authority>
    <authority>Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)</authority>
    <authority>Poland: Office for Registration of Medicinal Products, Medical Devices and Biocidal Products</authority>
    <authority>Romania: National Agency for Medicines and Medical Devices</authority>
    <authority>Sweden: Medical Products Agency</authority>
    <authority>Serbia and Montenegro: Agency for Drugs and Medicinal Devices</authority>
    <authority>Switzerland: Swissmedic</authority>
    <authority>Tunisia: Office of Pharmacies and Medicines</authority>
    <authority>Argentina: Administracion Nacional de Medicamentos, Alimentos y Tecnologia Medica</authority>
    <authority>Brazil: National Health Surveillance Agency</authority>
    <authority>Canada: Health Canada</authority>
    <authority>Chile: Instituto de Salud Pública de Chile</authority>
    <authority>Colombia: INVIMA Instituto Nacional de Vigilancia de Medicamentos y Alimentos</authority>
    <authority>Turkey:  General Directorate of Pharmaceuticals and Pharmacy</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy and safety of a continuous intravenous
      (IV) ularitide infusion on the clinical status and outcome of patients with acute
      decompensated heart failure (ADHF).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of the TRUE-AHF study is to evaluate the effect of a 48-h continuous IV
      infusion of ularitide (15 ng/kg/min) versus placebo on the clinical status of patients with
      acute decompensated heart failure (ADHF).

      The study drug will be administered in addition to the standard treatment. The nature of
      standard therapy will be carried out according to the clinical judgment of the Investigator
      and may include vasodilator, inotropic, and diuretic drugs, as clinically indicated.

      There are two co-primary endpoints for this study. Co-primary endpoint 1 will be a
      hierarchical clinical composite variable that includes a patient-centered assessment of
      clinical progress, an assessment of lack of improvement or worsening of HF requiring a
      pre-specified intervention, and death.

      The endpoint is intended to mimic the assessment that would be carried out by a physician
      caring for the patient. If, during the 48 h infusion, a patient's clinical course
      deteriorates because he/she dies, fails to improve or develops worsening HF requiring a
      pre-specified intervention or if the patient considers his/her general clinical status as
      moderately or markedly worse, the patient will be considered to be &quot;worse&quot;. If the patient
      considers his/her general clinical status as moderately or markedly improved and if such
      improvement is sustained without fulfilling the criteria for &quot;worse&quot; throughout the 48-h
      infusion (from 0 h to 48 h), the patient will be considered to be &quot;improved&quot;. If the patient
      is neither improved nor worse, the patient's clinical status will be considered to be
      &quot;unchanged&quot;.

      Co-primary efficacy endpoint 2 evaluates freedom from cardiovascular mortality during follow
      up after randomization, for the entire duration of the trial.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Anticipated">March 2015</completion_date>
  <primary_completion_date type="Anticipated">September 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Two Co-primary Efficacy Endpoints</measure>
    <time_frame>6, 24, 48 hours post infusion through the entire duration of the trial</time_frame>
    <safety_issue>No</safety_issue>
    <description>Improvement in a hierarchical clinical composite comprised of elements associated with: patient global assessment using a 7-point scale of symptomatic improvement, lack of improvement, or worsening; persistent or worsening heart failure (HF) requiring an intervention (initiation or intensification of IV therapy, circulatory or ventilatory mechanical support, surgical intervention, ultrafiltration, hemofiltration or dialysis); and all-cause mortality. Assessment of the clinical composite will be performed at 6 hour (h), 24 h and 48 h after start of IV ularitide infusion
Freedom from cardiovascular mortality during follow up after randomization, for the entire duration of the trial.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Secondary Endpoint</measure>
    <time_frame>48 hours post infusion start</time_frame>
    <safety_issue>No</safety_issue>
    <description>Changes of N-terminal pro brain natriuretic peptide (NT-pro BNP) at 48 h of treatment compared to baseline.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary Endpoint</measure>
    <time_frame>90 days after start of study drug infusion, including patients still hospitalized at Day 30</time_frame>
    <safety_issue>No</safety_issue>
    <description>All-cause mortality and cardiovascular rehospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary Endpoint</measure>
    <time_frame>90 days after start of study drug infusion, including patients still hospitalized at Day 30</time_frame>
    <safety_issue>No</safety_issue>
    <description>Cardiovascular rehospitalization</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">2152</enrollment>
  <condition>Acute Decompensated Heart Failure</condition>
  <arm_group>
    <arm_group_label>Ularitide</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ularitide, lyophilizate for i.v. infusion, 15 ng/kg BW/min, for 48 hours</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo lyophilizate for i.v. infusion</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ularitide</intervention_name>
    <arm_group_label>Ularitide</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Males and females aged 18 to 85 years.

          2. Unplanned hospitalization or emergency department visit for ADHF. Acute HF is defined
             as including all of the following:

               -  Dyspnea at rest in a recumbent sitting position (30 to 45 degrees), which  has
                  worsened within the past week

               -  Radiological evidence of HF on a chest X-ray

               -  Brain natriuretic peptide (BNP) &gt;500 pg/mL or N-terminal pro-brain natriuretic
                  peptide (NT-pro BNP) &gt;2000 pg/mL.

          3. Ability to start infusion of the study drug within 12 h after initial clinical
             assessment performed by a physician at the emergency room/hospital.

          4. Ability to reliably carry out self-assessment of symptoms.

          5. Systolic blood pressure ≥116 mmHg and ≤180 mmHg at the time of randomization.

          6. Persisting dyspnea at rest despite standard background therapy for ADHF (as
             determined by the Investigator) which must include IV furosemide (or equivalent
             diuretic) at ≥40 mg (or its equivalent) at any time after start of emergency services
             (ambulance, emergency department, or hospital). At the time of randomization, the
             patient must still be symptomatic. In addition, the patient should not have received
             an IV bolus of a diuretic for at least 2 h prior to randomization, and the infusion
             rates of ongoing IV infusions must not have been increased or decreased for at least
             2 h prior to randomization.

          7. Ability to understand the purpose and risks of the study and provide signed and dated
             informed consent and authorization to use protected health information (in accordance
             with national and local privacy regulations).

        Exclusion Criteria:

          1. Known active myocarditis, obstructive hypertrophic cardiomyopathy, congenital heart
             disease, restrictive cardiomyopathy, constrictive pericarditis, uncorrected
             clinically significant primary valvular disease.

          2. Treatment with dobutamine at a dose &gt;5 μg/kg/min or use of drugs for support of BP at
             the time of randomization.

          3. Treatment with levosimendan, milrinone, or any other phosphodiesterase inhibitor
             within 7 days before randomization.

          4. Treatment with nesiritide within 30 days before randomization.

          5. Creatinine clearance &lt;30 mL/min/1.73m² (as measured by the MDRD formula) at the time
             of screening.

          6. Planned coronary revascularization procedure (percutaneous coronary intervention or
             coronary artery bypass grafting) within 5 days of randomization.

          7. Clinical diagnosis of acute coronary syndrome meeting any 2 of the following 3
             criteria:

               -  Prolonged chest pain at rest, or an accelerated pattern of angina

               -  Electrocardiogram changes indicative of ischemia or myocardial injury defined
                  as: a new ST elevation at the J point of two anatomically contiguous leads with
                  the cut-off points:  ≥0.2 mV in men ≥40 years (&gt;0.25 mV in men &lt;40 years) or
                  ≥0.15 mV in women in leads V2-V3 and/or ≥0.1 mV in other leads; or ST depression
                  and T wave changes. New horizontal or down-sloping ST depression ≥0.05 mV in two
                  contiguous leads; and/or new T inversion

                    -  0.3 mV in two contiguous leads.

               -  Serum troponin &gt;3 times upper limit of normal.

          8. Clinically suspected acute mechanical cause of ADHF (e.g., papillary muscular
             rupture). The diagnosis need not be confirmed by imaging or cardiac catheterization.

          9. Anemia (hemoglobin &lt;9 g/dL or a hematocrit &lt;25%).

         10. Known vasculitis, active infective endocarditis, or suspected infections including
             pneumonia, acute hepatitis, systemic inflammatory response syndrome, or sepsis.

         11. Body temperature ≥38°C just prior to randomization.

         12. Acute or chronic respiratory disorder (e.g. severe chronic obstructive pulmonary
             disease) or primary pulmonary hypertension sufficient to cause dyspnea at rest, which
             may interfere with the ability to interpret dyspnea assessments or hemodynamic
             measurements.

         13. Terminal illness other than congestive heart failure with expected survival &lt;180
             days.

         14. Any previous exposure to ularitide.

         15. Known allergy to natriuretic peptides.

         16. Participation in an investigational clinical drug trial within 30 days prior to
             randomization.

         17. Current drug abuse or chronic alcoholism sufficient to impair participation and
             compliance to the study protocol.

         18. Women who are breast-feeding.

         19. Women of child-bearing potential (i.e. pre-menopausal women) without documentation of
             a negative urine/blood pregnancy assay within 12 h prior to randomization.

         20. Any condition that, in the Investigator's opinion, makes the patient unsuitable for
             study participation.

         21. Legal incapacity or limited legal capacity.

         22. Patients requiring mechanical circulatory support.

         23. Patients with severe hepatic impairment.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Milton Packer, MD</last_name>
    <role>Study Chair</role>
  </overall_official>
  <overall_official>
    <last_name>Christopher O'Connor, MD</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <overall_official>
    <last_name>William F Peacock, MD</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <overall_contact>
    <last_name>Matteo Mondellini</last_name>
    <phone>+39 02 93922665</phone>
    <email>matteo.mondellini@quintiles.com</email>
  </overall_contact>
  <location>
    <facility>
      <address>
        <city>Huntsville</city>
        <state>Alabama</state>
        <zip>35801</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>W. Herbert Haught, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Montgomery</city>
        <state>Alabama</state>
        <zip>36106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Steven O'Mara, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Deborah Diercks, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Trumbull</city>
        <state>Connecticut</state>
        <zip>06611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <zip>19718</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Mitchell Saltzberg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32216</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Michael Koren, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <address>
        <city>Aurora</city>
        <state>Illinois</state>
        <zip>60504</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <address>
        <city>Peoria</city>
        <state>Illinois</state>
        <zip>61606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Alexander Adler, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Rockford</city>
        <state>Illinois</state>
        <zip>61107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Gudmundur Gudmundsson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Anderson</city>
        <state>Indiana</state>
        <zip>46011</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Chad Cannon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Crestview Hills</city>
        <state>Kentucky</state>
        <zip>41017</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Damodhar Suresh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Alexandria</city>
        <state>Louisiana</state>
        <zip>71303</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Naseem Jaffrani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Sheveport</city>
        <state>Louisiana</state>
        <zip>71103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Nathan Shapiro, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Worcestor</city>
        <state>Massachusetts</state>
        <zip>01655</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Theo Meyer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Cristina Tita, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Phillip Levy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48235</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Philip Levy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Royal Oak</city>
        <state>Michigan</state>
        <zip>48073</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Carol Clark, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Troy</city>
        <state>Michigan</state>
        <zip>48073</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Aveh Bastani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55407</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55415</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>James Miner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Jackson</city>
        <state>Mississippi</state>
        <zip>39216</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <address>
        <city>Newark</city>
        <state>New Jersey</state>
        <zip>07107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Pallavi Solanki, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Snehal Patel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Lorenzo Paladino, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Flushing</city>
        <state>New York</state>
        <zip>11355</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Christopher Calandrella, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Stony Brook</city>
        <state>New York</state>
        <zip>11794</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Hal Skopicki, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Kirkwood Adams, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Brian Hiestand, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45219</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Gregory Fermann, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Jon Schrock, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Garrie Haas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Middletown</city>
        <state>Ohio</state>
        <zip>45005</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Rajan Krishnamani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43614</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Samer Khouri, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Zanesville</city>
        <state>Ohio</state>
        <zip>43701</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19141</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Dara Raspberry, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Paul Mather, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Gary Headden, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Chattanooga</city>
        <state>Tennessee</state>
        <zip>37403</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Carol Gruver, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Germantown</city>
        <state>Tennessee</state>
        <zip>38138</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Frank McGrew III, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Sean Collins, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Alpesh Amin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Hao Wang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Dick Kuo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Tony Ma, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Chris Ghaemmaghami, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Midlothian</city>
        <state>Virginia</state>
        <zip>23114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Shaival Kapadia, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23507</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>John Herre, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Keyur Shah, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Winchester</city>
        <state>Virginia</state>
        <zip>22601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <address>
        <city>Bellingham</city>
        <state>Washington</state>
        <zip>98225</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <address>
        <city>Ciudad Autonoma</city>
        <state>Buenos Aires</state>
        <zip>1180</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Ricardo Villarreal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Coronel Suarez</city>
        <state>Buenos Aires</state>
        <zip>B7540GHD</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Alberto Caccavo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>La Plata</city>
        <state>Buenos Aires</state>
        <zip>1900</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Luis Rodolfo Cartasegna, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>San Vicente</city>
        <state>Cordoba</state>
        <zip>5006</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Hugo A Luquez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Villa Cabrera</city>
        <state>Cordoba</state>
        <zip>X5008KKF</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Guillermo Moises Azize, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Rosario</city>
        <state>Santa Fe</state>
        <zip>2000</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Fabian Diez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>San Miguel de Tucuman</city>
        <state>Tucuman</state>
        <zip>4000</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Lilia Lobo Marquez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Cordoba</city>
        <zip>X5002AOQ</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Hugo Colombo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Cordoba</city>
        <zip>5000</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Lilia Beatriz Schiavi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Cordoba</city>
        <zip>5000</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Horacio` O Jure, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Cordoba</city>
        <zip>X5004BAL</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Daniela F Garcia Brasca, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Cordoba</city>
        <zip>X5000JHQ</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Julio Bono, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Cordoba</city>
        <zip>5016</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Marcos Amuchastegui, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Corrientes</city>
        <zip>W3400AMZ</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Eduardo R Perna, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>San Miguel de Tucuman</city>
        <zip>T4000NIL</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Eduardo Hasbani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Santa Fe</city>
        <zip>S3000FUJ</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Miguel A Hominal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Santa Fe</city>
        <zip>S3000EOZ</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Mario A Berli, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Red Deer</city>
        <state>Alberta</state>
        <zip>T4N 1T6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Gustavo Nogareda, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Victoria</city>
        <state>British Columbia</state>
        <zip>V8R 6R5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <zip>B3H 2Y9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Miroslaw Rajda, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Kitchener</city>
        <state>Ontario</state>
        <zip>N2M 1B2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Stuart Smith, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Sainte-Foy</city>
        <state>Quebec</state>
        <zip>G1V 4G5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Marie-Hélène Leblanc, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Sherbrooke</city>
        <state>Quebec</state>
        <zip>J1H5N4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <address>
        <city>Santiago</city>
        <zip>8320112</zip>
        <country>Chile</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Pablo Castro, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Santiago</city>
        <zip>8050000</zip>
        <country>Chile</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Jorge L Cobos Segarra, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Santiago</city>
        <zip>7630000</zip>
        <country>Chile</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <address>
        <city>Barranquilla</city>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Carlos H Cotes Aroca, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Bogota</city>
        <zip>00000</zip>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Monica Lopez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Bogota</city>
        <zip>00000</zip>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>David Espinosa, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Cali</city>
        <zip>00000</zip>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <address>
        <city>Floridablanca</city>
        <zip>00000</zip>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Luis E Echeverria, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Medellin</city>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <address>
        <city>Brno</city>
        <zip>625 00</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Jindrich Spinar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Brno</city>
        <zip>65691</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <address>
        <city>Brno</city>
        <zip>65691</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Lenka Spinarova, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Frydek-Mistek</city>
        <zip>73818</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Kamil Zeman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Hradec Kralove</city>
        <zip>50012</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Radek Pudil, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Liberec</city>
        <zip>460 63</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <address>
        <city>Olomouc</city>
        <zip>775 20</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Milos Taborsky, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Praha 10</city>
        <zip>100 34</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Zuzana Motovska, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Praha 2</city>
        <zip>128 08</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Tomas Janota, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Praha 4</city>
        <zip>140 00</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Jiri Kettner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Praha 5</city>
        <zip>150 30</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>David Alan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Znojmo</city>
        <zip>669 02</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Zdenek Monhart, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Tallinn</city>
        <zip>10617</zip>
        <country>Estonia</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <address>
        <city>Tallinn</city>
        <zip>10138</zip>
        <country>Estonia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Tiina Uuetoa, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Tallinn</city>
        <zip>13419</zip>
        <country>Estonia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Pentti Põder, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Espoo</city>
        <zip>02740</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Johan Lassus, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Helsinki</city>
        <zip>00290</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <address>
        <city>Oulu</city>
        <zip>90220</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <address>
        <city>Besançon Cedex</city>
        <state>Doubs</state>
        <zip>25030</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Marie-France Seronde, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Toulouse Cedex 9</city>
        <state>Haute Garonne</state>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Michel Galinier, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Paris cedex 10</city>
        <state>Paris</state>
        <zip>75475</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Alain Cohen-Solal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Bron cedex</city>
        <state>Rhone</state>
        <zip>69677</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Eric Bonnefoy-Cudraz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Nuernberg</city>
        <state>Bayern</state>
        <zip>90419</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Michael Christ, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Bad Nauheim</city>
        <state>Hessen</state>
        <zip>61231</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Veselin Mitrovic, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Gross-Umstadt</city>
        <state>Hessen</state>
        <zip>64823</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Michael Weber, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Langen</city>
        <state>Hessen</state>
        <zip>63225</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Hans-Georg Olbrich, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Greifswald</city>
        <state>Mecklenburg Vorpommern</state>
        <zip>17475</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Stephan Felix, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Bochum</city>
        <state>Nordrhein Westfalen</state>
        <zip>44787</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Christoph Hanefeld, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Siegen</city>
        <state>Nordrhein Westfalen</state>
        <zip>57072</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Michael Buerke, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Erfurt</city>
        <state>Thueringen</state>
        <zip>99089</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Harald Lapp, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Budapest</city>
        <zip>1096</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Gabor Z Piroth, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Debrecen</city>
        <zip>4032</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Zoltan Szabo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Debrecen</city>
        <zip>4032</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Istvan Edes, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Nyiregyhaza</city>
        <zip>4400</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Zsolt Koszegi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Bologna</city>
        <zip>40138</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Mario Cavazza, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Genova</city>
        <zip>16132</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Paolo Moscatelli, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Milano</city>
        <zip>20138</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Alessandro Salvioni, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Napoli</city>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Giorgio Cinquegrana, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Novara</city>
        <zip>28100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Giancarlo Avanzi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Roma</city>
        <zip>00189</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Salvatore Di Somma, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Riga</city>
        <zip>LV1002</zip>
        <country>Latvia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Andrejs Erglis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Kaunas</city>
        <zip>45130</zip>
        <country>Lithuania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Liucija Jodziuniene, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Kaunas</city>
        <zip>50009</zip>
        <country>Lithuania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Ausra Kavoliuniene, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Vilnius</city>
        <zip>08661</zip>
        <country>Lithuania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Pranas Serpytis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Beverwijk</city>
        <zip>1942 LE</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Iris Westendorp, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Breda</city>
        <zip>4818 CK</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>P.H.J.M. Dunselman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Ede</city>
        <zip>6716 RP</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>F.R. Den Hartog</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Gorinchem</city>
        <zip>4204 AA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Piet van Rossum, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Groningen</city>
        <zip>9713 GZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Peter van der Meer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Harderwijk</city>
        <zip>3844 DG</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <address>
        <city>Leiderdorp</city>
        <zip>2353 GA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>D J Van der Heijden, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Sneek</city>
        <zip>8601 ZK</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>H. Swart, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Tilburg</city>
        <zip>5022 GC</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <address>
        <city>Krakow</city>
        <zip>31-202</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Piotr Podolec, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Krakow</city>
        <zip>31-121</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Ewa Mirek-Bryniarska, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Lodz</city>
        <zip>91-347</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Jaroslaw Kasprzak, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Warszawa</city>
        <zip>04-628</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Jacek Grzybowski, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Warszawa</city>
        <zip>04-628</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Janina Stepinska, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Warszawa</city>
        <zip>03-242</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Miroslaw Dluzniewski, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Wroclaw</city>
        <zip>50-981</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Piotr Ponikowski, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Bucuresti</city>
        <zip>021659</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Sorin Costel Stamate, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Bucuresti</city>
        <zip>050098</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Dragos Vinereanu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Iasi</city>
        <zip>700503</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Catalina Arsenescu Georgescu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Oradea</city>
        <zip>410169</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Mircea Popescu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Belgrade</city>
        <zip>11040</zip>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Petar Otasevic, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Belgrade</city>
        <zip>11080</zip>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Slavica Radovanovic, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Belgrade</city>
        <zip>11000</zip>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Petar Seferovic, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Nis</city>
        <zip>18000</zip>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Milan Pavlovic, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Niska Banja</city>
        <zip>18205</zip>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Stevan Ilic, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Sremska Kamenica</city>
        <zip>21204</zip>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Slobodan Dodic, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Zemun</city>
        <zip>11080</zip>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Aleksandar Neskovic, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>L'Hospitalet de Llobregat</city>
        <state>Barcelona</state>
        <zip>08907</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Javier Jacob Rodriguez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Sant Joan Despí</city>
        <state>Barcelona</state>
        <zip>08970</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Josep Masip, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Aranjuez</city>
        <state>Madrid</state>
        <zip>28300</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Rafael Blancas Gomez-Casero, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Alicante</city>
        <zip>03010</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Pere Llorens, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Barcelona</city>
        <zip>08025</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Alessandro Sionis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>F. Javier Martin Sanchez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Basel</city>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Christian Mueller, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Lugano</city>
        <zip>6900</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Tiziano Moccetti, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Zuerich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Ulf Landmesser, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Eskisehir</city>
        <zip>26480</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Yuksel Cavusoglu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Istanbul</city>
        <zip>34662</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Hakan Altay, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Kocaeli</city>
        <zip>41300</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Dilek Ural, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Samsun</city>
        <zip>55139</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Serkan Yuksel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Sivas</city>
        <zip>58140</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>TRUE-AHF@quintiles.com</email>
    </contact>
    <investigator>
      <last_name>Mehmet Birhan Yilmaz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
    <country>Argentina</country>
    <country>Canada</country>
    <country>Chile</country>
    <country>Colombia</country>
    <country>Czech Republic</country>
    <country>Estonia</country>
    <country>Finland</country>
    <country>France</country>
    <country>Germany</country>
    <country>Hungary</country>
    <country>Italy</country>
    <country>Latvia</country>
    <country>Lithuania</country>
    <country>Netherlands</country>
    <country>Poland</country>
    <country>Romania</country>
    <country>Serbia</country>
    <country>Spain</country>
    <country>Switzerland</country>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Mitrovic V, Lüss H, Nitsche K, Forssmann K, Maronde E, Fricke K, Forssmann WG, Meyer M. Effects of the renal natriuretic peptide urodilatin (ularitide) in patients with decompensated chronic heart failure: a double-blind, placebo-controlled, ascending-dose trial. Am Heart J. 2005 Dec;150(6):1239.</citation>
    <PMID>16338265</PMID>
  </reference>
  <reference>
    <citation>Mitrovic V, Seferovic PM, Simeunovic D, Ristic AD, Miric M, Moiseyev VS, Kobalava Z, Nitsche K, Forssmann WG, Lüss H, Meyer M. Haemodynamic and clinical effects of ularitide in decompensated heart failure. Eur Heart J. 2006 Dec;27(23):2823-32. Epub 2006 Oct 30.</citation>
    <PMID>17074775</PMID>
  </reference>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 24, 2014</lastchanged_date>
  <firstreceived_date>July 31, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Acute decompensated heart failure</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Atrial natriuretic factor prohormone (95-126)</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
